Description
Buy T3 Liothyronine Sodium + SR-9011 + Yohimbine
This combination brings together three compounds with substantially different mechanisms: liothyronine (T3), a thyroid hormone; SR-9011, an investigational REV-ERB agonist; and yohimbine, an alpha-2 adrenergic antagonist. The combination itself has not been established in controlled human clinical research.
Product Information
Liothyronine is synthetic triiodothyronine and has established medical use in thyroid hormone replacement. SR-9011 is a synthetic REV-ERB agonist investigated primarily in cellular and animal metabolic research. Yohimbine blocks alpha-2 adrenergic receptors and has been studied in human metabolic and cardiovascular research.
How Does It Work?
T3 directly activates thyroid hormone receptors and influences metabolic gene expression. SR-9011 modulates REV-ERB-related circadian and metabolic signaling, while yohimbine increases sympathetic activity by blocking alpha-2 adrenergic receptors. These pathways are mechanistically distinct, and their combined effects have not been clinically validated.
POTENTIAL BENEFITS
Thyroid & Metabolic Research
T3 provides a well-characterized model for studying thyroid-hormone regulation of metabolic rate, mitochondrial activity, and energy expenditure.
Circadian-Metabolic Research
SR-9011 is used experimentally to investigate REV-ERB signaling, circadian rhythm regulation, metabolism, and cellular energy pathways.
Adrenergic Research
Yohimbine provides a pharmacological model for studying alpha-2 adrenergic blockade, sympathetic activity, and catecholamine-related metabolic responses.
Energy-Expenditure Research
The three components have individually generated interest in energy metabolism, although there is no human evidence demonstrating that this specific combination safely or effectively increases fat loss.
Side Effects
T3 can produce symptoms of excessive thyroid hormone exposure, including palpitations, tremor, anxiety, sweating, insomnia, and cardiovascular strain. Yohimbine may increase blood pressure, heart rate, anxiety, or agitation. SR-9011 lacks an established human safety profile.
Dosage
There is no validated dosage for this combination. Human clinical dosing of liothyronine is indication-specific, while human research on yohimbine has used substantially different protocols. SR-9011 has not undergone established human therapeutic dosing. These figures should not be combined into a stack dosage.
Where to Buy T3 Liothyronine Sodium + SR-9011 + Yohimbine
Purerawz does not directly sell this combination. Readers should verify the identity, concentration, purity, and analytical documentation of each component.
References
Walsh JP et al. Combined thyroxine/liothyronine treatment of hypothyroidism: a randomized controlled trial.
Solt LA et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature. 2012;485:62-68.
Kucio C et al. Does yohimbine act as a slimming drug?
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party suppliers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information on these pages is provided for educational and informational purposes only. Dosage figures may reflect published research protocols or reported community use and should not be interpreted as personalized medical instructions. Research findings, particularly animal and early-stage studies, do not necessarily translate into established human benefits or safety.
Reviews
There are no reviews yet.